Trial Profile
An Open-Label, Phase I Study to Assess Absorption, Metabolism and Excretion of a Single Oral Dose of [14C]AZD0530 in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2009
Price :
$35
*
At a glance
- Drugs Saracatinib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 20 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2009 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 10 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.